IL4 and hepatocellular carcinoma: With respect to HCC, only two studies were found regarding the IL-4 −590 C/T polymorphism and HCC risk in a high-risk Chinese population [46] and in low-risk non-Asians in the USA [22], both conducted by Ognjanovic et al. [22], [46].